Novartis Faces Third Clinical-Trial Setback in a Week as Muscle Drug Fails
Novartis has encountered its third clinical trial failure in a week, as a muscle drug did not meet its primary endpoint in a late-stage study.
Category: Health
Novartis Encounters Third Clinical Trial Setback in a Week
Novartis has encountered its third clinical trial failure in a week, as a muscle drug did not meet its primary endpoint in a late-stage study.
Novartis Faces Third Clinical Trial Setback in a Week as Muscle Drug Fails
Novartis has encountered its third clinical trial failure in a week, as a muscle drug did not meet its primary endpoint in a late-stage study.